Showing 1331-1340 of 7784 results for "".
Pruritus: A Marker For Cancer?
https://practicaldermatology.com/topics/practice-management/pruritus-a-marker-for-cancer/21181/Though the relationship is well known, new studies validate concerns regarding the link between pruritus and malignancy.Biologics and Pediatric Psoriasis
https://practicaldermatology.com/topics/practice-management/biologics-and-pediatric-psoriasis/21196/Though data has been lacking in recent years, the use of biologics in pediatric and adolescent patients deserves more consideration.Financial Focus for Young Physicians
https://practicaldermatology.com/topics/practice-management/financial-focus-for-young-physicians-first-build-your-foundation/21416/Two important steps young dermatologists should take now for future financial security.Isotretinoin: Expanding Access to Improve Outcomes
https://practicaldermatology.com/topics/acne-rosacea/isotretinoin-expanding-access-to-improve-outcomes/22961/A new pharmacy service program seeks to support patient education, streamline testing, and expedite access to isotretinoin—taking responsibility off of practices.Updating Approaches to Psoriasis
https://practicaldermatology.com/topics/psoriasis/evaluating-the-state-of-psoriasis-care/21660/Recent guidelines from the National Psoriasis Foundation point to new directions in research and therapy that will continue to shape psoriasis therapy.Adjusting to a Paradigm Shift in Documentation
https://practicaldermatology.com/topics/practice-management/adjusting-to-a-paradigm-shift-in-documentation/21681/Clinicians can navigate changing rules by selecting technologies that accommodate rapid shifts in documentation.Lasers in Practice: Devices for Non-Invasive Fat Reduction
https://practicaldermatology.com/topics/general-topics/lasers-in-practice-devices-for-non-invasive-fat-reduction/21998/While most devices are investigational, and long-term studies are needed, early evidence is promising for non-invasive fat reduction.Assessing Clinical Options for Moderately Dysplastic Nevi Excised with Positive Margins
https://practicaldermatology.com/topics/skin-cancer-photoprotection/assessing-clinical-options-for-moderately-dysplastic-nevi-excised-with-positive-margins/20322/The latest data support the decision to monitor patients rather than re-excise when the pathology report confirms moderate dysplasia with positive margins.Preparing for Private Equity: Benefits and Drawbacks
https://practicaldermatology.com/issues/september-2025/preparing-for-private-equity-benefits-and-drawbacks/37629/Over the past decade, the health care industry has emerged as a prime target for private equity (PE) investment.A Practical Primer for Dysport, Part 1: Speaking the Language and Strategies for Success with the Glabella and Forehead
https://practicaldermatology.com/topics/general-topics/PD0709_09-php/22804/To gain the most benefit from the newest botulinum neurotoxin, clinicians need to think about the product in its own terms.